FABIANI, IACOPO
 Distribuzione geografica
Continente #
NA - Nord America 3.204
AS - Asia 2.902
EU - Europa 2.409
SA - Sud America 601
AF - Africa 75
Continente sconosciuto - Info sul continente non disponibili 59
OC - Oceania 7
Totale 9.257
Nazione #
US - Stati Uniti d'America 3.009
SG - Singapore 1.092
IT - Italia 915
CN - Cina 736
RU - Federazione Russa 674
BR - Brasile 470
VN - Vietnam 358
BD - Bangladesh 234
HK - Hong Kong 150
GB - Regno Unito 132
DE - Germania 125
NL - Olanda 118
FR - Francia 105
CA - Canada 103
FI - Finlandia 88
TR - Turchia 63
IN - India 60
SE - Svezia 52
MX - Messico 51
PL - Polonia 44
IE - Irlanda 40
AR - Argentina 39
ID - Indonesia 31
ZA - Sudafrica 31
EC - Ecuador 30
IQ - Iraq 28
ES - Italia 26
PK - Pakistan 23
JP - Giappone 20
UA - Ucraina 20
CO - Colombia 18
AT - Austria 15
MY - Malesia 15
IL - Israele 14
SA - Arabia Saudita 14
VE - Venezuela 14
MA - Marocco 12
LT - Lituania 11
AE - Emirati Arabi Uniti 9
PE - Perù 9
BE - Belgio 8
PY - Paraguay 8
UZ - Uzbekistan 8
EG - Egitto 7
CL - Cile 6
CR - Costa Rica 6
DO - Repubblica Dominicana 6
JM - Giamaica 6
JO - Giordania 6
NP - Nepal 6
AU - Australia 5
CH - Svizzera 5
DZ - Algeria 5
GR - Grecia 5
KE - Kenya 5
KZ - Kazakistan 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
GT - Guatemala 4
KR - Corea 4
LB - Libano 4
PH - Filippine 4
RO - Romania 4
CZ - Repubblica Ceca 3
HU - Ungheria 3
MG - Madagascar 3
SI - Slovenia 3
SV - El Salvador 3
TH - Thailandia 3
TN - Tunisia 3
TW - Taiwan 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GD - Grenada 2
HN - Honduras 2
KG - Kirghizistan 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CG - Congo 1
CU - Cuba 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
HR - Croazia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
Totale 9.191
Città #
Dallas 818
Singapore 605
Ashburn 346
San Jose 337
Beijing 243
Hong Kong 145
Moscow 135
Council Bluffs 132
Ho Chi Minh City 126
Los Angeles 116
Milan 106
New York 99
Santa Clara 71
Hanoi 70
Rome 70
São Paulo 61
The Dalles 58
Munich 51
Helsinki 48
Lauterbourg 45
Hefei 43
Buffalo 40
Dublin 40
Boardman 39
Warsaw 37
Naples 36
Florence 35
Istanbul 35
London 35
Pisa 34
Denver 29
Orem 29
Lappeenranta 28
Mexico City 28
Montreal 28
Frankfurt am Main 26
Houston 26
Amsterdam 24
Brooklyn 24
Johannesburg 24
Beauharnois 23
Chicago 23
Phoenix 23
Genoa 22
Chennai 21
Rio de Janeiro 21
Atlanta 20
Haiphong 20
Lucca 19
Nuremberg 19
Seattle 19
Tokyo 19
Toronto 19
Stockholm 17
Da Nang 16
Poplar 16
Boston 14
Mumbai 13
Palermo 13
Bologna 12
Brescia 12
Cascina 12
Curitiba 12
Manchester 12
Guayaquil 11
Paris 11
San Francisco 11
Turin 11
Washington 11
Ankara 10
Assago 10
Belo Horizonte 10
Biên Hòa 10
Quito 10
Bari 9
Brasília 9
Hangzhou 9
Kuala Lumpur 9
Shenzhen 9
Tel Aviv 9
Turku 9
Charlotte 8
Chengdu 8
Dhaka 8
Guangzhou 8
Hillsboro 8
Hải Dương 8
Porto Alegre 8
Salt Lake City 8
Brussels 7
Figino 7
Goiânia 7
Lahore 7
Livorno 7
Milwaukee 7
Phủ Lý 7
Queens 7
Shanghai 7
Vienna 7
Casablanca 6
Totale 5.047
Nome #
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 628
Trastuzumab cardiotoxicity and drug cardioprotection in healthy and cardiac dysfunction mouse models 382
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 322
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 293
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 268
Atrial amyloidosis: mechanisms and clinical manifestations 268
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 262
Valve disease in cardiac amyloidosis: an echocardiographic score 261
Disease features and management of cardiomyopathies in women 258
Assessing cardiac mechanics through left ventricular haemodynamic forces 249
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 247
Multi-chamber speckle tracking imaging and diagnostic value of left atrial strain in cardiac amyloidosis 241
Role of Imaging in Cardiomyopathies 241
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 241
Valvular heart disease in patients with cardiac amyloidosis 240
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi 239
Etiological Treatment of Cardiac Amyloidosis: Standard of Care and Future Directions 225
Sex-specific associations of myocardial perfusion imaging with outcomes in patients with suspected chronic coronary syndrome 219
Use of new and emerging cancer drugs: what the cardiologist needs to know 218
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 217
Management and treatment of cardiotoxicity due to anticancer drugs: 10 questions and answers 214
Clinical management of drug-induced cardiotoxicity in patients with HER-2+ breast cancer: current recommendations and future outlook 209
Cardiovascular toxicity from therapies for light chain amyloidosis 206
The Mayo ATTR‐CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis 198
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 195
Treatment Options in AF Patients with Cancer; Focus on Catheter Ablation 188
Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study 186
Advancing Cardiovascular Risk Stratification and Functional Assessment: A Narrative Review of CPET and ESE Applications 182
Echocardiographic Estimate of Pulmonary Capillary Wedge Pressure Improves Outcome Prediction in Heart Failure Patients with Reduced and Mildly Reduced Ejection Fraction 179
Magnetic resonance imaging for diagnostic workup of embolic stroke of undetermined source: A systematic review 179
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 178
Critical Reading of cardiovascular trials with neutral or negative results 173
Galectin-3 and Risk for Cancer or Heart Failure: Does Sex Matter? 165
Partial Lipodystrophy and LMNA p.R545H Variant 162
Exercise oscillatory ventilation in heart failure and brain–lung–heart–muscle crosstalk 161
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation 158
Ischemic Heart Disease in Liver Transplant Candidates With High Bleeding Risk: Any Way Out? 157
More cardiopulmonary effort testing needed in HFpEF! 145
Non-pegylated liposomal doxorubicin in older adjuvant early breast cancer patients: cardiac safety analysis and final results of the COLTONE study 134
Safety and Effectiveness of Sodium-Glucose Co-Transporter 2 Inhibitors in Active Cancer Patients with Heart Failure: Results of the Observational TOSCA Trial 122
Response to ‘Is the left atrium the key in the amyloid imaging lock?’ 116
Serum and Tissue Light-Chains as Disease Biomarkers in AL Amyloidosis 65
PAWP vs LVEDP During Invasive Cardiopulmonary Exercise Testing: In Search of the Holy Grail of a Hemodynamic Truth in Heart Failure. 37
null 29
Totale 9.257
Categoria #
all - tutte 39.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.094


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202347 0 0 0 0 4 5 4 6 18 5 5 0
2023/2024246 1 0 48 34 10 22 30 8 6 16 14 57
2024/20252.115 40 48 85 51 121 122 291 414 200 149 276 318
2025/20266.553 379 726 859 941 619 466 559 313 447 433 443 368
2026/2027296 168 128 0 0 0 0 0 0 0 0 0 0
Totale 9.257